← 返回

长链非编码 RNA UGDH-AS1 在三阴性乳腺癌中编码抑制 NK 细胞的微肽

英文原题:The long non-coding RNA UGDH-AS1 encodes an NK-cell-inhibiting micropeptide in triple-negative breast cancers.

查看英文原题

The long non-coding RNA UGDH-AS1 encodes an NK-cell-inhibiting micropeptide in triple-negative breast cancers.

PubMed 2025/12/12(内容时间) Nat Commun Q1 · IF 18.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

NK细胞在抗肿瘤免疫应答中很重要,因为它们具有杀伤MHC I类缺陷肿瘤细胞的潜能,但它们在免疫敌对的肿瘤微环境中常变得功能失调。在这里,我们利用单细胞RNA测序鉴定出一个对三阴性乳腺癌(TNBC)亚型具有特异性的NK细胞亚群,其特征是表达长链非编码RNA UGDH-AS1。在这些NK细胞中,UGDH-AS1编码微肽NKSM,后者使这些NK细胞因丧失其激活程序而功能失调,从而导致癌症进展。将NKSM条件性敲入小鼠NK细胞会导致NK细胞失活和移植瘤生长增加。靶向NKSM治疗有效减少TNBC小鼠模型中的肿瘤生长。

我们发现,UGDH-AS1 + NK细胞受到肿瘤微环境(TME)的塑造。在被TGF-信号通路上调后,NKSM与Myc结合,抑制其在Serine 62位点由ERK1/2介导的磷酸化,从而降低其稳定性。Myc活性降低导致T-bet失调,T-bet是参与NK细胞功能的关键蛋白,进而导致NK细胞失活。

因此,我们的研究为TNBC中NK细胞功能障碍提供了机制性见解,并为靶向NK细胞的TNBC免疫治疗提供了原理验证。

展开英文摘要原文

NK cells are important for the anti-tumour immune response for their potential to kill MHC class I-deficient tumor cells, but they often become dysfunctional in the immune-hostile tumour microenvironment.

Here, using single-cell RNA sequencing, we identify an NK cell subpopulation that is specific to triple-negative breast cancers (TNBC) subtype, characterised by the expression of the long non-coding RNA UGDH-AS1.

In these NK cells, UGDH-AS1 encodes the micropeptide, NKSM, which renders these NK cells dysfunctional due to the loss of their activation program, which leads to cancer progression. Conditional NKSM knock-in into NK cells of mice results in NK cell deactivation and increased growth of transplanted tumours. Targeted NKSM therapy effectively reduces tumor growth in TNBC mouse models.

We find that UGDH-AS1 + NK cells are shaped by the tumor microenvironment (TME). Following upregulation by the TGF- signaling pathway, NKSM binds to Myc, inhibiting its ERK1/2-mediated phosphorylation at Serine 62 and thus reducing its stability. Decreased Myc activity results in deregulation of T-bet, a key protein involved in NK cell function, which leads to NK cell deactivation.

Our study thus provides mechanistic insight int NK cell dysfunctionality in TNBC and lays down the proof of principle for an NK-cell-targeting TNBC immunotherapy.

论文信息

作者
Zhang Z、Li F、Dai X、Deng J、Guo B、Wang Y、Liu W、Pan Y
第一作者单位
Jiangsu Clinical Medicine Research Institute, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.China
通讯作者单位
Jiangsu Clinical Medicine Research Institute, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. zhouyifeng@njmu.edu.cn.China
期刊
Nature communications2025 Dec 12
原文标识
PubMed 41387419 · DOI 10.1038/s41467-025-66266-x